ALZN saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 77 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ALZN turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 33 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
ALZN moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALZN crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALZN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALZN's RSI Indicator exited the oversold zone, 36 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 50-day moving average for ALZN moved above the 200-day moving average on September 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +5.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALZN advanced for three days, in 174 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
ALZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 71 of 82 cases where ALZN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.040) is normal, around the industry mean (2.988). P/E Ratio (-0.616) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. ALZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ASBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 17 of 22 cases where ASBP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ASBP as a result. In 37 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 47%.
The Moving Average Convergence Divergence (MACD) for ASBP just turned positive on October 20, 2026. Looking at past instances where ASBP's MACD turned positive, the stock continued to rise in 19 of 44 cases over the following month. The odds of a continued upward trend are 43%.
ASBP moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASBP advanced for three days, in 65 of 125 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for ASBP crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 27%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for ASBP entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.056) is normal, around the industry mean (0.880). P/E Ratio (-1.331) is within average values for comparable stocks, (39.798). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.471). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (28.818) is also within normal values, averaging (49.084).
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ASBP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
| ALZN | ASBP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | N/A |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 32% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 47% |
| MACD ODDS (%) | 2 days ago 89% | 2 days ago 43% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 46% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 45% |
| Advances ODDS (%) | 4 days ago 81% | 2 days ago 52% |
| Declines ODDS (%) | 2 days ago 90% | 15 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 72% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALZN’s FA Score shows that 0 FA rating(s) are green while ASBP’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALZN’s TA Score shows that 6 TA indicator(s) are bullish while ASBP’s TA Score has 5 bullish TA indicator(s).
ALZN (@Biotechnology) experienced а -7.41% price change this week, while ASBP (@Auto Parts: OEM) price change was +8.46% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.04%. For the same industry, the average monthly price growth was -18.13%, and the average quarterly price growth was -15.32%.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was -4.68%. For the same industry, the average monthly price growth was -11.28%, and the average quarterly price growth was -19.03%.
ALZN is expected to report earnings on Dec 08, 2026.
ASBP is expected to report earnings on Nov 13, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Auto Parts: OEM (-4.68% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with VRAX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then VRAX could also see price increases.
| Ticker / NAME | Correlation To ALZN | 1D Price Change % | ||
|---|---|---|---|---|
| ALZN | 100% | -3.10% | ||
| VRAX - ALZN | 46% Loosely correlated | -2.19% | ||
| FTH - ALZN | 41% Loosely correlated | -1.06% | ||
| LTRN - ALZN | 38% Loosely correlated | +4.28% | ||
| ASBP - ALZN | 38% Loosely correlated | +1.49% | ||
| SILO - ALZN | 33% Loosely correlated | +1.67% | ||
More | ||||
A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.
| Ticker / NAME | Correlation To ASBP | 1D Price Change % | ||
|---|---|---|---|---|
| ASBP | 100% | +1.49% | ||
| SPRO - ASBP | 42% Loosely correlated | -4.10% | ||
| ALZN - ASBP | 38% Loosely correlated | -3.10% | ||
| DCOY - ASBP | 31% Poorly correlated | -5.73% | ||
| CMPX - ASBP | 28% Poorly correlated | -2.26% | ||
| INTS - ASBP | 27% Poorly correlated | -1.86% | ||
More | ||||